A First Music Festival Visit It"s hard to imagine a more contentious relationship than that between President Bush and the Press Corps. Will that animus the press displayed toward President Bush be carried over to our new Chief Executive? It could seem weird to pick your audience prior sport wristbands to selecting the topic of discussion however by selecting your optimal audience initially you"ll be able to hone into what your audiences interests and pain points are. Add music. There are times when the sounds of nature are perfect to accompany your exercise. Then, there are the times when your soul feels the need to bust a move! The right music at the right time can be all the motivation you need to keep going. Go on, shake your groove thing! It"s good for you. During Big Boi"s spring 2013 North American tour the rapper will perform 43 concerts over a two month time span. He will not only be performing headlining shows but will also make appearances at the Beale Street festival wristbands, Summer Camp festival wristbands, and at the NXNE Festival. One of the principal risks with this strategy is a sudden and very sharp move against you (usually this occurs on the downside, so is more relevant for sellers of bull put spreads). If you are concerned about this happening, you could always enter a stop loss order just on your sold option. By doing this, if the market moves quickly, you will get out of your sold option, limiting your losses and hold only the long option which may end up making a profit if the market continues in that direction. These gains will help, and could potentially even outstrip the losses made on the sold option. If you"re worried about a "flash crash" event wristbands, this is one way to protect yourself. Zoo Grass provides entertainment from Mean Green Music that can be enjoyed while you are taking in all of the sites of the zoo. It is included in admission. Killer Mike will open all headlining concerts. Tickets for Big Boi"s spring 2013 "Shoes For Running" tour go on sale beginning March 8. For more information about Big Boi"s North American tour visit his official website here.

[Photo/VCG]

Vaccine candidate offers prospect of better protection against cervical cancer

Chinese researchers have taken a major step forward in developing a new-generation vaccine with the potential to offer protection against almost all the most lethal forms of human papilloma virus, or HPV.

HPV is primarily transmitted through sexual contact. More than 200 distinct HPV types have been identified, of which at least 18 are high-risk types associated with 99 percent of cervical cancers, the second-most-common cancer among women, after breast cancer.

The Gardasil 9 HPV vaccine, which is currently available, provides the broadest protection against infection from nine HPV types, seven of which can cause 90 percent of cervical cancers. However, it remains unclear whether widespread immunization with vaccines like Gardasil 9 could lead to an increase in infection rates from the other cancer-related HPV types.

To expand type coverage, the approach used in previous vaccines was to increase the number of virus-like particles. One particle resembles one HPV type, and it can elicit immunity to that type. The more particles a vaccine has, the broader the protection it provides.

However, this approach is fraught with difficulties, as an increase in type coverage dramatically enhances protein amounts and immunological agent levels per dose, causing side effects such as pain, swelling and fever and raising manufacturing complexity and production costs.

Researchers at Xiamen University in Fujian province have developed a new vaccine candidate that can protect against more HPV types with fewer particles.

They divided 20 major HPV types - including HPV6 and HPV11, which account for 90 percent of genital warts - into seven groups based on genetic relationships and found that genetically close HPV types share high structural similarities.

Lead researcher Xia Ningshao compared the virus or the vaccine to a "ball". All HPV types are similar in appearance, but differ significantly on the ball"s surface, with features such as veins and convex and concave areas. These structural features on the surface are called loops.

"Because of the loops, one type of vaccine can stimulate the production of antibodies only against the infection of one type of virus, and is unable to prevent infection by other types," Xia said.

Using a loop-swapping approach, researchers engineered a complex virus-like particle with the loops of three genetically close HPV types: HPV33, HPV58 and HPV52.

They tested the triple-type particle in experiments on mice and monkeys, and found it could provide high immune potency - comparable to a combination of three virus-like particles.

The new approach was equally successful in developing another four triple-types using the other 12 major HPV types.

"The research paves the way for an improved HPV vaccine made of seven triple-type virus-like particles to protect against as many as 20 HPV types," Xia said.

The results were recently published in the international journal Nature Communications. Reviewers said the new-generation vaccine candidate was "a remarkable achievement" for having broader type coverage, lower cost and lower amounts of proteins and agents, and "will be moved forward into a clinical trial".

Three HPV vaccines have been introduced in China, covering two, four and nine types. The three-shot HPV vaccination covering nine types is priced at 3,894 yuan ($567). In some areas, scalpers sell doctors" appointments to get it for more than 6,000 yuan, a cost that is prohibitive for many poor women.

Researchers say the new-generation vaccine candidate will be available for females age 9 to 45, and its cost will not exceed that of the vaccines currently available.

Two HPV vaccines previously developed by Xiamen University have reached the clinical test stage and are expected to enter the market this year and in 2022.

The world"s first HPV vaccine, Gardasil, was developed by Chinese cancer researcher Zhou Jian, who died in 1999, and Australian immunologist Ian Frazer. In 1995, they started cooperating with Merck and Co to develop the vaccine.

According to the World Health Organization, there are about 570,000 new cases of cervical cancer, and 311,000 deaths from the disease, reported worldwide every year. China has a high incidence and death rate, with 106,000 new cases reported last year and about 48,000 deaths.

Xinhua


charity bracelets uk
team bride wristbands
24 hour bracelets
personalized silicone bracelets
paper wristbands uk